gut
microbiom
consid
role
develop
infecti
process
beyond
clostridium
difficil
infect
respect
bacteri
complic
taur
et
al
perform
studi
allogen
hematopoiet
stem
cell
transplant
hsct
recipi
report
enterococcu
gut
domin
increas
risk
futur
develop
enterococcu
sepsi
differ
cohort
allogen
hsct
recipi
tamburini
et
al
strain
level
analysi
bloodstream
isol
report
strain
escherichia
coli
klebsiella
pneumonia
caus
septicemia
like
origin
relationship
gut
microbiota
develop
viral
infect
howev
well
describ
studi
mice
shown
relationship
gut
microbiota
impair
viral
clearanc
abt
et
al
investig
antibiot
administr
mous
model
lymphocyt
choriomening
viru
found
antibiot
administr
led
decreas
innat
viral
immun
respons
well
delay
studi
reveal
butyr
product
certain
gut
anaerob
bacteria
immunomodulatori
role
contribut
overal
health
distant
site
haak
et
al
investig
role
gut
bpg
bacteria
futur
develop
viral
infect
cohort
allogen
hsct
recipi
report
rel
gut
abund
bpg
bacteria
associ
less
futur
develop
lower
respiratori
viral
base
upon
studi
profil
gut
microbiota
use
rrna
gene
sequenc
region
fecal
specimen
kidney
transplant
recipi
report
rel
abund
bpg
bacteria
associ
less
risk
develop
respiratori
viral
infect
kidney
transplant
recipi
provid
support
find
haak
et
al
august
novemb
kidney
transplant
recipi
consent
serial
collect
fecal
specimen
kidney
transplant
recipi
provid
least
one
fecal
specimen
gut
microbi
profil
among
kidney
transplant
recipi
subject
provid
fecal
specimen
week
day
day
subject
provid
least
one
fecal
specimen
first
day
transplant
pool
individu
mean
analysi
demograph
clinic
characterist
collect
chart
review
studi
approv
weill
cornel
institut
review
board
subject
provid
written
inform
consent
kidney
transplant
recipi
provid
fecal
specimen
use
commod
specimen
collect
kit
thermo
fisher
scienc
fecal
specimen
aliquot
approxim
mg
aliquot
subsequ
store
recipi
ask
provid
specimen
week
dna
extract
rrna
gene
amplif
rrna
gene
region
perform
describ
lee
et
sequenc
pcr
amplicon
perform
illumina
miseq
platform
base
pair
base
pair
bioinformat
taxonom
classif
perform
describ
lee
et
briefli
taxonomi
determin
use
nucleotid
refer
train
set
ncbi
minimum
threshold
respiratori
viru
infect
cmv
viremia
bk
viremia
determin
review
electron
medic
record
subject
posit
respiratori
viru
infect
defin
posit
test
result
use
respiratori
panel
biofir
diagnost
llc
cmv
viremia
defin
posit
result
detect
level
use
pcr
assay
cornel
cmv
pcr
test
perform
routin
subject
everi
month
first
year
transplant
bk
viremia
defin
posit
result
detect
level
use
pcr
assay
cornel
quest
diagnost
llc
bk
viru
pcr
test
perform
routin
subject
everi
month
first
year
transplant
everi
month
second
year
transplant
distribut
continu
variabl
analyz
use
wilcoxon
test
unpair
valu
wilcoxon
test
pair
valu
distribut
categor
variabl
analyz
use
fisher
exact
test
cox
regress
hazard
model
use
estim
whether
rel
gut
abund
bpg
bacteria
associ
decreas
risk
develop
respiratori
viru
infect
cmv
viremia
bk
viremia
surviv
curv
construct
compar
use
test
analys
perform
r
rstudio
among
fecal
specimen
kidney
transplant
recipi
mean
standard
deviat
amount
high
qualiti
rrna
bacteri
gene
sequenc
overal
demograph
transplant
characterist
subject
present
tabl
bpg
speci
speci
detect
tabl
sum
rel
gut
abund
bpg
bacteria
calcul
fecal
specimen
defin
hereaft
rel
gut
abund
bpg
bacteria
mean
rel
gut
abund
bpg
bacteria
among
fecal
specimen
standard
deviat
top
bpg
speci
faecalibacterium
prausnitzii
mean
holdemanella
biformi
eubacterium
dolichum
coprococcu
come
subdoligranulum
variabil
eubacterium
rectal
heatmap
rel
gut
abund
top
speci
among
fecal
specimen
present
figur
figur
show
chang
rel
gut
abund
bpg
bacteria
first
month
transplant
fecal
specimen
kidney
transplant
recipi
evalu
role
antibiot
besid
pneumocysti
jiroveci
prophylaxi
preoper
antibiot
prophylaxi
rel
gut
abund
bpg
bacteria
first
month
transplant
among
kidney
transplant
recipi
subject
receiv
addit
antibiot
first
month
transplant
provid
fecal
specimen
abx
group
subject
receiv
addit
antibiot
provid
fecal
specimen
abx
group
rel
gut
abund
bpg
bacteria
significantli
lower
abx
group
abx
group
median
vs
median
p
wilcoxon
test
figur
order
understand
individu
subject
chang
rel
gut
abund
bpg
bacteria
time
evalu
subject
pair
week
week
fecal
specimen
among
subject
subject
receiv
addit
antibiot
pair
abx
group
subject
receiv
antibiot
day
week
fecal
specimen
collect
day
week
fecal
specimen
collect
pair
abx
group
list
antibiot
administ
pair
abx
group
found
tabl
pair
abx
group
signific
chang
rel
gut
abund
bpg
bacteria
week
week
median
vs
respect
p
wilcoxon
test
figur
pair
abx
group
signific
chang
rel
gut
abund
bpg
bacteria
week
week
median
vs
respect
p
wilcoxon
test
figur
next
evalu
subgroup
subject
pair
abx
group
receiv
anaerob
antibiot
coverag
anaerob
antibiot
coverag
includ
follow
antibiot
metronidazol
carbapenem
clindamycin
combin
penicillin
inhibitor
oral
rational
evalu
antibiot
anaerob
coverag
base
strict
anaerob
natur
mani
bpg
bacteria
eg
faecalibacterium
prausnitzii
eubacterium
rectal
among
pair
abx
group
subject
anaerob
antibiot
coverag
signific
decreas
rel
gut
abund
bpg
bacteria
week
week
median
vs
respect
p
wilcoxon
test
figur
also
evalu
whether
rel
gut
abund
bpg
bacteria
associ
gender
age
greater
year
old
african
american
race
induct
therapi
steroid
mainten
therapi
kidney
function
month
post
transplant
antibiot
associ
decreas
abund
bpg
bacteria
evalu
pair
specimen
subject
receiv
antibiot
week
week
pair
abx
group
rel
gut
abund
bpg
bacteria
significantli
lower
femal
group
male
group
median
vs
p
wilcoxon
test
figur
significantli
lower
steroid
mainten
group
steroid
free
group
median
vs
p
wilcoxon
test
figur
signific
associ
rel
gut
abund
bpg
bacteria
age
greater
year
old
african
american
race
induct
therapi
kidney
function
month
post
transplant
figur
f
evalu
whether
rel
gut
abund
bpg
bacteria
associ
decreas
risk
viral
infect
develop
kidney
transplant
recipi
three
interv
month
post
transplant
year
post
transplant
year
post
transplant
evalu
rel
gut
abund
bpg
bacteria
fecal
specimen
collect
week
examin
associ
week
timefram
approxim
engraft
time
allogen
hsct
recipi
given
variabl
gut
microbiota
also
evalu
mean
rel
gut
abund
bpg
bacteria
fecal
specimen
obtain
within
first
day
transplant
subject
also
examin
associ
final
respect
bpg
rel
gut
abund
cutoff
higher
bpg
group
lower
bpg
group
analyz
rel
gut
abund
cutoff
util
haak
et
al
bottom
quartil
cutoff
median
cutoff
among
cohort
kidney
graft
recipi
develop
document
respiratori
viral
rv
infect
respiratori
panel
first
year
transplant
common
first
detect
rv
infect
includ
rhinovirusenteroviru
n
coronaviru
n
influenza
n
median
time
first
rv
infect
day
interquartil
rang
day
day
transplant
patient
document
cmv
viremia
first
year
transplant
median
time
first
detect
cmv
viremia
day
interquartil
rang
day
day
transplant
patient
document
bk
viremia
first
year
transplant
median
time
first
detect
bk
viremia
day
interquartil
rang
day
day
transplant
cutoff
rel
gut
abund
bpg
bacteria
subject
provid
week
fecal
specimen
subject
lower
bpg
bacteria
group
subject
higher
bpg
bacteria
group
higher
bpg
bacteria
group
decreas
risk
develop
rv
infect
month
post
transplant
hr
hazard
ratio
ci
confid
interv
p
figur
year
post
transplant
ci
p
figur
year
post
transplant
ci
p
figur
compar
lower
bpg
bacteria
group
higher
bpg
bacteria
group
decreas
risk
develop
cmv
viremia
year
post
transplant
ci
p
figur
year
post
transplant
ci
p
figur
compar
lower
bpg
bacteria
group
signific
differ
hazard
ratio
higher
bpg
bacteria
group
lower
bpg
bacteria
group
respect
futur
develop
bk
viremia
month
post
transplant
p
figur
year
post
transplant
p
figur
year
post
transplant
ci
p
figur
bottom
quartil
cutoff
rel
gut
abund
bpg
bacteria
subject
provid
week
fecal
specimen
subject
lower
bpg
bacteria
group
subject
higher
bpg
bacteria
group
higher
bpg
bacteria
group
decreas
risk
develop
rv
infect
month
post
transplant
ci
p
figur
year
post
transplant
ci
p
figur
compar
lower
bpg
bacteria
group
signific
differ
hazard
ratio
higher
bpg
bacteria
group
lower
bpg
bacteria
group
respect
futur
develop
cmv
viremia
bk
viremia
month
year
year
post
transplant
p
figur
median
cutoff
rel
gut
abund
bpg
bacteria
subject
provid
week
fecal
specimen
subject
lower
bpg
bacteria
group
subject
higher
bpg
bacteria
group
signific
differ
hazard
ratio
higher
bpg
bacteria
group
lower
bpg
bacteria
group
respect
futur
develop
rv
infect
cmv
viremia
bk
viremia
month
year
year
post
transplant
p
figur
subject
provid
least
one
fecal
specimen
first
month
transplant
subject
mean
rel
gut
abund
bpg
bacteria
among
fecal
specimen
first
month
transplant
calcul
cutoff
mean
rel
abund
bpg
bacteria
subject
lower
bpg
bacteria
group
subject
higher
bpg
bacteria
group
higher
bpg
bacteria
group
decreas
risk
develop
rv
infect
month
post
transplant
ci
p
figur
year
post
transplant
ci
p
figur
year
post
transplant
ci
p
figur
compar
lower
bpg
bacteria
group
higher
bpg
bacteria
group
decreas
risk
develop
cmv
viremia
year
post
transplant
ci
p
figur
compar
lower
bpg
bacteria
group
signific
differ
hazard
ratio
higher
bpg
bacteria
group
lower
bpg
bacteria
group
respect
futur
develop
bk
viremia
month
year
year
post
transplant
p
figur
bottom
quartil
cutoff
mean
rel
gut
abund
bpg
bacteria
subject
lower
bpg
bacteria
group
subject
higher
bpg
bacteria
group
higher
bpg
bacteria
group
decreas
risk
develop
rv
infect
month
post
transplant
ci
p
figur
year
post
transplant
ci
p
figur
year
post
transplant
ci
p
figur
compar
lower
bpg
bacteria
group
signific
differ
hazard
ratio
higher
bpg
bacteria
group
lower
bpg
bacteria
group
respect
futur
develop
cmv
viremia
bk
viremia
month
year
year
post
transplant
p
figur
median
quartil
cutoff
mean
rel
gut
abund
bpg
bacteria
subject
lower
bpg
bacteria
group
subject
higher
bpg
bacteria
group
higher
bpg
bacteria
group
decreas
risk
develop
rv
infect
month
post
transplant
ci
p
figur
compar
lower
bpg
bacteria
group
signific
differ
hazard
ratio
higher
bpg
bacteria
group
lower
bpg
bacteria
group
respect
futur
develop
cmv
viremia
bk
viremia
month
year
year
post
transplant
p
figur
studi
report
one
first
descript
gut
bacteria
time
kidney
transplant
popul
data
reveal
antibiot
anaerob
coverag
associ
decreas
rel
gut
abund
bpg
bacteria
data
also
support
relationship
high
rel
gut
abund
bpg
bacteria
less
risk
develop
respiratori
viral
infect
find
first
observ
haak
et
al
allogen
hsct
import
note
allogen
hsct
subject
much
higher
proport
patient
less
rel
gut
abund
bpg
bacteria
kidney
transplant
recipi
studi
vs
respect
specul
differ
like
higher
number
antibiot
given
allogen
hsct
popul
studi
found
antibiot
anaerob
coverag
associ
decreas
rel
gut
abund
bpg
bacteria
week
week
kidney
transplant
recipi
usual
receiv
preoper
antibiot
surgic
prophylaxi
pneumocysti
jiroveci
prophylaxi
routin
receiv
antibiot
anaerob
coverag
differ
antibiot
regimen
may
explain
dichotomi
rel
gut
abund
bpg
bacteria
two
popul
also
found
gender
steroid
mainten
therapi
associ
lower
rel
gut
abund
bpg
bacteria
could
also
contribut
dichotomi
respect
gender
littl
known
differ
rel
gut
abund
bpg
men
women
recent
studi
gao
et
al
note
differ
gut
microbiota
obes
individu
stratifi
possibl
gender
may
contribut
differ
rel
gut
abund
bpg
bacteria
may
implic
immun
system
modul
beyond
viral
infect
sever
limit
relat
studi
first
signific
gap
time
stool
specimen
evalu
time
viral
diagnos
limit
data
suggest
stabil
rel
gut
abund
bpg
bacteria
subject
receiv
antibiot
rel
gut
abund
bpg
bacteria
may
chang
cours
time
set
antibiot
usag
account
surviv
curv
analys
addit
use
cutoff
rel
gut
abund
bpg
bacteria
util
allogen
hsct
recipi
notabl
signific
differ
proport
hsct
recipi
proport
kidney
transplant
recipi
less
rel
gut
abund
bpg
bacteria
whether
cutoff
also
relev
kidney
transplant
popul
unknown
order
address
concern
evalu
bottom
quartil
cutoff
well
median
cutoff
find
associ
high
rel
gut
abund
bpg
bacteria
decreas
risk
respiratori
viral
infect
use
bottom
quartil
cutoff
anoth
limit
respiratori
viral
panel
perform
clinician
indic
basi
unlik
bk
viru
cmv
viru
screen
perform
routin
per
protocol
subject
respiratori
viral
symptom
screen
use
respiratori
viral
panel
may
influenc
result
furthermor
subject
may
asymptomat
long
term
respiratori
viral
infect
prior
transplant
whether
detect
result
new
infect
asymptomat
colon
known
also
note
studi
evalu
upper
respiratori
viral
infect
haak
et
al
studi
assess
lower
respiratori
viral
infect
whether
data
appli
lower
respiratori
viral
infect
kidney
transplant
popul
unknown
given
limit
number
outcom
perform
multivari
analys
possibl
factor
may
confound
result
despit
limit
preliminari
studi
provid
one
first
descript
bpg
bacteria
kidney
transplant
recipi
earli
kidney
transplant
find
antibiot
anaerob
coverag
associ
decreas
rel
gut
abund
bpg
bacteria
also
report
associ
rel
gut
abund
bpg
bacteria
risk
develop
respiratori
viral
infect
kidney
transplant
recipi
result
preliminari
natur
requir
replic
larger
cohort
kidney
transplant
recipi
particular
report
trend
toward
signific
associ
rel
gut
abund
bpg
bacteria
cmv
viremia
would
need
valid
cmv
viremia
find
well
cmv
diseas
studi
examin
rel
gut
abund
bpg
bacteria
futur
studi
examin
absolut
gut
abund
bpg
bacteria
andor
fecal
butyr
concentr
may
provid
insight
relationship
bpg
bacteria
develop
viral
complic
nevertheless
find
confirm
data
support
therapeut
option
form
modul
gut
microbiota
decreas
viral
infect
rate
author
manuscript
follow
compet
interest
disclos
egp
receiv
speaker
honoraria
bristol
myer
squibb
celgen
sere
therapeut
medimmun
novarti
fer
pharmaceut
inventor
patent
applic
entitl
method
composit
reduc
clostridium
difficil
infect
entitl
method
composit
reduc
enterococci
infect
colon
hold
patent
receiv
royalti
sere
therapeut
inc
jrl
receiv
research
support
biofir
diagnost
llc
dd
ms
jrl
inventor
patent
applic
entitl
method
detect
dna
biolog
sampl
mm
ltz
sa
ee
particip
process
specimen
data
analysi
jh
cg
an
yt
particip
data
analysi
tm
ml
dmd
particip
data
analysi
write
manuscript
jrl
egp
ms
particip
studi
design
data
analysi
write
manuscript
